Cargando…
Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early-onset Alzheimer’s disease, in which amyloid-β accumulates in the brain. Amyloid-β is a product of the chromosome 21 gene APP (amyloid precursor protein) and the extra copy or ‘dose’ of APP...
Autores principales: | Tosh, Justin L., Rhymes, Elena R., Mumford, Paige, Whittaker, Heather T., Pulford, Laura J., Noy, Sue J., Cleverley, Karen, Walker, Matthew C., Tybulewicz, Victor L. J., Wykes, Rob C., Fisher, Elizabeth M. C., Wiseman, Frances K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952899/ https://www.ncbi.nlm.nih.gov/pubmed/33707583 http://dx.doi.org/10.1038/s41598-021-85062-3 |
Ejemplares similares
-
Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models
por: Tosh, Justin L., et al.
Publicado: (2021) -
Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome
por: Cannavo, Claudia, et al.
Publicado: (2022) -
The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model
por: Wu, Yixing, et al.
Publicado: (2021) -
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP
por: Wiseman, Frances K, et al.
Publicado: (2018) -
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
por: Wu, Yixing, et al.
Publicado: (2023)